Ocular Therapeutix, Inc. at the Jefferies 2019 London Healthcare Conference 2019
Thursday, November 21, 2019 8:40 AM GMT
Q3 2019 Ocular Therapeutix, Inc. Earnings Conference Call
Tuesday, November 12, 2019 8:00 AM EST

Corporate Profile

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Our product pipeline candidates utilize the hydrogel technology to provide differentiated drug delivery solutions that are designed to reduce the complexity and burden of current drop or injection regimens by creati
(Common Stock)

Copyright West LLC. Minimum 15 minutes delayed.